The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ponatinib (PON) in patients (pts) with chronic-phase chronic myeloid leukemia (CP-CML) and the T315I mutation (mut): 4-year results from OPTIC.
 
Michael Deininger
Employment - Versiti Blood Research Institute
Leadership - Versiti Blood Research Institute
Honoraria - Blueprint Medicines; CTI BioPharma Corp; Incyte; Novartis; Pfizer
Consulting or Advisory Role - Blueprint Medicines; CTI BioPharma Corp; CTI BioPharma Corp; Novartis
Research Funding - Blueprint Medicines
Travel, Accommodations, Expenses - Blueprint Medicines; Novartis
 
Jane Apperley
Honoraria - Bristol Myers Squibb Foundation; Incyte; Novartis; Pfizer
Speakers' Bureau - Bristol Myers Squibb Foundation; Incyte; Novartis; Pfizer
Research Funding - Incyte; Pfizer
 
Christopher Kevin Arthur
No Relationships to Disclose
 
Charles Chuah
Honoraria - Bristol Myers Squibb Foundation; Novartis; Otsuka
Research Funding - Bristol Myers Squibb Foundation; Novartis; Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Andreas Hochhaus
Honoraria - Incyte (Inst); Novartis (Inst); Pfizer (Inst)
Consulting or Advisory Role - Incyte; Novartis
Research Funding - Enliven Therapeutics (Inst); Incyte (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Hugues de Lavallade
Honoraria - Bristol Myers Squibb Foundation; Incyte; Novartis; Pfizer
Research Funding - Bristol Myers Squibb Foundation; Incyte
 
Jeffrey Howard Lipton
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Novartis; Pfizer; Takeda
 
Elza Lomaia
Speakers' Bureau - Fusion Pharmaceuticals; Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis; Pfizer
 
James K. McCloskey
No Relationships to Disclose
 
Lori J. Maness
Employment - Syneos Health (I)
 
Michael J. Mauro
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; Takeda
Research Funding - Bristol-Myers Squibb; Novartis; Pfizer; Sun Pharma Advanced Research Company; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer; Takeda
 
Beatriz Moiraghi
Speakers' Bureau - Novartis; Pfizer; Takeda
 
Carolina Pavlovsky
Consulting or Advisory Role - Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer; Pint Pharma
 
Gianantonio Rosti
Speakers' Bureau - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Research Funding - Pfizer
 
Philippe Rousselot
No Relationships to Disclose
 
Maria Undurraga Sutton
Consulting or Advisory Role - Abbvie; Janssen; Novartis; Pfizer; Roche
Speakers' Bureau - Janssen; Novartis; Pfizer
 
Xiaowei Ren
Employment - Takeda
 
Alexander Vorog
Employment - Takeda
 
Hagop M. Kantarjian
Honoraria - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; ARIAD; BMS Brazil; ImmunoGen; Orsenix; Pfizer; Takeda
Research Funding - Abbvie (Inst); Agios (Inst); Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); ImmunoGen (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst)
 
Jorge E. Cortes
Consulting or Advisory Role - Bio-Path Holdings, Inc; Gilead Sciences; Novartis; Pfizer; Rigel; Sun Pharma; Takeda; Terns Pharmaceuticals
Research Funding - Abbvie/Genentech (Inst); Actuate Therapeutics (Inst); Bio-Path Holdings, Inc (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Sellas Life Sciences (Inst); Sun Pharma (Inst); Takeda (Inst)